VITAE PHARMACEUTICALS INC - COM (VTAE)

CUSIP: 92847N103

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / COM
Total 13F shares
24,224,131
Share change
+3,190,907
Total reported value
$506,763,396
Put/Call ratio
231%
Price per share
$20.92
Number of holders
98
Value change
+$158,101,235
Number of buys
72
Number of sells
38

Quarterly Holders Quick Answers

What is CUSIP 92847N103?
CUSIP 92847N103 identifies VTAE - VITAE PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of VITAE PHARMACEUTICALS INC - COM (VTAE) as of Q3 2016

As of 30 Sep 2016, VITAE PHARMACEUTICALS INC - COM (VTAE) was held by 98 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,224,131 shares. The largest 10 holders included ALPINE ASSOCIATES MANAGEMENT INC., Allianz Asset Management GmbH, TIG Advisors, LLC, WATER ISLAND CAPITAL LLC, Magnetar Financial LLC, BlackRock Fund Advisors, GARDNER LEWIS ASSET MANAGEMENT L P, AWM Investment Company, Inc., CNH PARTNERS LLC, and VANGUARD GROUP INC. This page lists 98 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.